UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 191

Sortiert nach

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.51-57

2016

Volltextzugriff (PDF)

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia

Leukemia, 2010-06, Vol.24 (6), p.1152-1159

2010

Volltextzugriff (PDF)

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Blood, 2023-06, Vol.141 (25), p.3055-3064

2023

Volltextzugriff (PDF)

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

Leukemia, 2017-10, Vol.31 (10), p.2247-2251

2017

Volltextzugriff (PDF)

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

Leukemia, 2012-07, Vol.26 (7), p.1475-1481

2012

Volltextzugriff (PDF)

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia

Leukemia, 2011-04, Vol.25 (4), p.638-647

2011

Volltextzugriff (PDF)

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia

Leukemia, 2005-05, Vol.19 (5), p.750-758

2005

Volltextzugriff (PDF)

Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia

Cell death discovery, 2016-01, Vol.2 (1), p.15070-15070, Article 15070

2016

Volltextzugriff (PDF)

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

Blood advances, 2021-05, Vol.5 (9), p.2375-2384

2021

Volltextzugriff (PDF)

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD‐1 inhibitors

Journal of the European Academy of Dermatology and Venereology, 2022-01, Vol.36 (S1), p.41-44

2022

Volltextzugriff (PDF)

Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

Cell death discovery, 2016-05, Vol.2 (1), p.16010-16010, Article 16010

2016

Volltextzugriff (PDF)

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.216-221

2017

Volltextzugriff (PDF)

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia

Leukemia, 2003-12, Vol.17 (12), p.2426-2434

2003

Volltextzugriff (PDF)

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

Leukemia, 2012-09, Vol.26 (9), p.2039-2051

2012

Volltextzugriff (PDF)

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

Leukemia, 2002, Vol.16 (1), p.30-35

2002

Volltextzugriff (PDF)

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2022-06, Vol.22 (6), p.382-392

2022

Volltextzugriff (PDF)

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)

Leukemia, 2007-10, Vol.21 (10), p.2153-2163

2007

Volltextzugriff (PDF)

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients

Annals of oncology, 2012-04, Vol.23 (4), p.990-996

2012

Volltextzugriff (PDF)

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status

Leukemia, 2006-10, Vol.20 (10), p.1774-1782

2006

Volltextzugriff (PDF)

Differential expression of chemokine receptors in B cell malignancies

Leukemia, 2001-05, Vol.15 (5), p.752-756

2001

Volltextzugriff (PDF)

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial

Annals of hematology, 2013-11, Vol.92 (11), p.1521-1528

2013

Volltextzugriff (PDF)

Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells

Leukemia research, 2008-10, Vol.32 (10), p.1565-1572

2008

Volltextzugriff (PDF)

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Leukemia, 2013-10, Vol.27 (10), p.2102-2105

2013

Volltextzugriff (PDF)

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Annals of oncology, 2008-03, Vol.19 (3), p.545-552

2008

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Englisch
(161)
Deutsch
(31)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Humans
(119)
Science & Technology
(118)
Life Sciences & Biomedicine
(116)
Female
(70)
Hematology
(70)
Male
(67)
Biological And Medical Sciences
(62)
Medical Sciences
(54)
Middle Aged
(54)
Oncology
(40)
Adult
(39)
Aged
(39)
Hematologic And Hematopoietic Diseases
(35)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(33)
Animals
(28)
Prognosis
(25)
Leukemia
(23)
Mice
(21)
Flow Cytometry
(17)
Aged, 80 And Over
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(25)
Blood
(21)
Deutsche Medizinische Wochenschrift
(17)
Annals Of Hematology
(10)
British Journal Of Haematology
(9)
European Journal Of Haematology
(6)
Leukemia Research
(6)
Annals Of Oncology
(5)
Der Internist
(4)
Hematological Oncology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia

Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD‐1 inhibitors

Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status

Differential expression of chemokine receptors in B cell malignancies

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial

Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

S125: 10‐DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS‐SG

Suchergebnisse filtern